RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
This Quarter Return
+12.07%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$1.23B
AUM Growth
+$1.23B
(+18%)
Cap. Flow
+$106M
Cap. Flow
% of AUM
8.59%
Top 10 Holdings %
Top 10 Hldgs %
30.7%
Holding
101
New
8
Increased
39
Reduced
39
Closed
6
Top Buys
| 1 |
Inspire Medical Systems
INSP
|
$22.2M |
| 2 |
Exact Sciences
EXAS
|
$21.8M |
| 3 |
Medtronic
MDT
|
$14.4M |
| 4 |
Novo Nordisk
NVO
|
$11.9M |
| 5 |
CVS Health
CVS
|
$11.6M |
Top Sells
| 1 |
UnitedHealth
UNH
|
$19.1M |
| 2 |
Elevance Health
ELV
|
$18.4M |
| 3 |
Oscar Health
OSCR
|
$11.4M |
| 4 |
Cigna
CI
|
$11.3M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
$9.67M |
Sector Composition
| 1 | Healthcare | 100% |
| 2 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Boston Scientific
BSX
$156B
| $49.4M | 4.01% | 590,000 -5,000 | -0.8% | -$419K |
|
|
2
UnitedHealth
UNH
$281B
| $42.5M | 3.45% | 72,700 -32,600 | -31% | -$19.1M |
|
3
Eli Lilly
LLY
$657B
| $42.1M | 3.42% | 47,500 +500 | +1% | +$443K |
|
4
Regeneron Pharmaceuticals
REGN
$61.5B
| $41M | 3.33% | 39,000 +7,000 | +22% | +$7.36M |
|
5
Tenet Healthcare
THC
$16.3B
| $36.8M | 2.99% | 221,400 -7,600 | -3% | -$1.26M |
|
6
Procept Biorobotics
PRCT
$2.23B
| $35.7M | 2.89% | 445,000 +5,000 | +1% | +$401K |
|
7
AbbVie
ABBV
$372B
| $35M | 2.84% | 177,000 -12,000 | -6% | -$2.37M |
|
|
8
Medtronic
MDT
$119B
| $33.1M | 2.69% | 368,000 +160,000 | +77% | +$14.4M |
|
|
9
Exact Sciences
EXAS
$8.98B
| $31.7M | 2.57% | 465,000 +320,000 | +221% | +$21.8M |
|
10
HCA Healthcare
HCA
$94.5B
| $31M | 2.51% | 76,229 -5,771 | -7% | -$2.35M |
|
11
Intuitive Surgical
ISRG
$170B
| $31M | 2.51% | 63,000 +2,500 | +4% | +$1.23M |
|
12
Gilead Sciences
GILD
$140B
| $30.7M | 2.49% | 366,500 +128,000 | +54% | +$10.7M |
|
13
Natera
NTRA
$23.1B
| $29.3M | 2.38% | 231,000 +74,000 | +47% | +$9.39M |
|
|
14
Oscar Health
OSCR
$4.31B
| $29.1M | 2.36% | 1,371,147 -535,464 | -28% | -$11.4M |
|
15
Merck
MRK
$210B
| $27.4M | 2.22% | 241,000 +66,000 | +38% | +$7.49M |
|
16
Becton Dickinson
BDX
$55.3B
| $27.1M | 2.2% | 112,500 -500 | -0.4% | -$121K |
|
|
17
Elevance Health
ELV
$71.8B
| $26.3M | 2.13% | 50,500 -35,300 | -41% | -$18.4M |
|
|
18
Inspire Medical Systems
INSP
$2.77B
| $25.7M | 2.09% | 122,000 +105,000 | +618% | +$22.2M |
|
19
BioMarin Pharmaceuticals
BMRN
$11.2B
| $25.6M | 2.08% | 364,500 +113,000 | +45% | +$7.94M |
|
20
Cooper Companies
COO
$13.4B
| $25.2M | 2.04% | 228,000 -82,000 | -26% | -$9.05M |
|
21
Alignment Healthcare
ALHC
$3.24B
| $23.4M | 1.9% | 1,977,363 +335,915 | +20% | +$3.97M |
|
22
Danaher
DHR
$147B
| $23.2M | 1.88% | 83,302 +34,802 | +72% | +$9.68M |
|
23
Vertex Pharmaceuticals
VRTX
$100B
| $22.2M | 1.8% | 47,750 -6,250 | -12% | -$2.91M |
|
24
Royalty Pharma
RPRX
$15.6B
| $17.4M | 1.41% | 613,500 +68,803 | +13% | +$1.95M |
|
25
Thermo Fisher Scientific
TMO
$186B
| $15.5M | 1.26% | 25,100 +1,100 | +5% | +$680K |
|